Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,888
Total Claims
$795K
Drug Cost
521
Beneficiaries
$1,525
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+43%
Cost per patient vs peers
$1,525 vs $1,068 avg
+44%
Brand preference vs peers
12.9% vs 9.0% avg
Brand vs Generic
Brand: 1,142 claims · $649K
Generic: 7,681 claims · $144K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 157 | $178K |
| Empagliflozin | 116 | $111K |
| Apixaban | 94 | $77K |
| Dapagliflozin Propanediol | 64 | $53K |
| Rivaroxaban | 17 | $25K |
| Dulaglutide | 20 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 25 | $14K |
| Budesonide/Formoterol Fumarate | 30 | $14K |
| Semaglutide | 11 | $11K |
| Budesonide/Glycopyr/Formoterol | 15 | $9,757 |
| Fluticasone/Umeclidin/Vilanter | 14 | $9,183 |
| Metoprolol Succinate | 368 | $8,160 |
| Insulin Glargine,hum.Rec.Anlog | 13 | $8,084 |
| Evolocumab | 12 | $7,158 |
| Rosuvastatin Calcium | 147 | $6,720 |
Prescribing Profile
Patient Profile
73
Avg Age
42%
Female
1.10
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data